Tagreed Alkaltham/Linkedin
Feb 10, 2026, 15:35
Tagreed Alkaltham։ Correcting Anemia Matters, But Restoring Iron Stores Determines Resilience
Tagreed Alkaltham, Transfusion Medicine Lab Supervisor at KSMC, shared a post on LinkedIn:
”Iron Is Not a Supplement.
It’s a System Choice.
Correcting anemia matters.
But restoring iron stores is what determines resilience after blood loss.
We often talk about transfusion as if it starts in the operating room.
It doesn’t.
- Long before fibrinogen is considered,
- before ICS is activated,
- before the blood bank phone rings,there is a quieter decision that already shaped the outcome.
Iron.
- In Patient Blood Management, iron is not just about correcting a lab value.
It’s about building functional reserve before it is tested. - A patient who enters surgery iron deficient
enters already fragile.
And when bleeding occurs, even expected bleeding,
the margin for safety disappears quickly. - Not because surgery failed.
- But because preparation did.
From a blood bank perspective:
- iron optimization is one of the most underused transfusion avoidance strategies.
- It reduces unnecessary transfusion demand,
protects limited blood inventory,
and shifts pressure away from emergency decisions. - PBM is not anti-transfusion.It is anti-late decisions.
Because by the time we debate hemoglobin thresholds,the most important decision has already been missed.
(That decision was preparation, not transfusion)
Building resilience before blood is needed where PBM truly begins․”
Stay updated with Hemostasis Today.
-
Feb 10, 2026, 16:52Understanding Risks Factors of Cancer-Associated Thrombosis – World Thrombosis Day
-
Feb 10, 2026, 16:50Sophia Delicou: Does Hepatic Dysfunction Truly Reflect Thrombotic Risk in Hemoglobinopathies?
-
Feb 10, 2026, 16:42Veronica Sanchez: AHA Scientific Statement on Maternal Stroke in Pregnancy and Postpartum
-
Feb 10, 2026, 16:40Arsene Mekinian: Multidisciplinary Specialties Forum on Pulmonology and Internal Medicine
-
Feb 10, 2026, 16:35Abdul Mannan: Advances in the Management of Von Willebrand Disease
-
Feb 10, 2026, 16:16Wolfgang Miesbach: How ‘Benign’ PDE Inhibitors Shape Platelet Function
-
Feb 10, 2026, 16:14Yves Bikoromana: What Every Lab and Clinician Should Know on Pseudothrombocytopenia
-
Feb 10, 2026, 16:11NTLM Webinar on Major Haemorrhage Simulations – National Blood Transfusion Committee
-
Feb 10, 2026, 16:07Abhishek Kumar: Next-Generation Treatments Transforming Polycythemia Vera Care